|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||20.79 - 21.05|
|52 Week Range||14.27 - 22.83|
|PE Ratio (TTM)||43.80|
|Dividend & Yield||0.33 (1.57%)|
|1y Target Est||N/A|
Is Grifols (GRFS) a great pick from the value investor's perspective right now? Read on to know more.
The biotech sector has turned around after its dismal performance in 2016 as uncertainty surrounding drug pricing control subsides. A few stocks are however still undervalued, which may gain going ahead.
A Relative Strength Rating upgrade for Grifols shows improving technical performance.